P-124De novo malignancies in patients after liver transplantation: A single centre experience

Introduction: De novo malignancy is a major cause of long term morbidity and mortality in patients after liver transplantation (LTx). The overall risk is estimated to be 2-4 times higher as compared to general population. Neither cancer screening protocols, nor universal recommendations have yet been established. The aim of this study was to evaluate incidence of de novo malignancies, identify potential risk factors and characterise the overall outcome of patients after LTx.
Source: Annals of Oncology - Category: Cancer & Oncology Source Type: research